AIDA-0493 and AIDA-2000 protocol design. IDA indicates idarubicin; MTZ, mitoxantrone; VP-16, etoposide; ARA-C, cytarabine; 6-TG, 6-thioguanine; and CHT, chemotherapy (6-mercaptopurine + methotrexate).